SEC Comment Letter for HEALTHEQUITY, (HQY) — Oct 6, 2022
HEALTHEQUITY, INC.
Date: Oct. 6, 2022 · CIK: 0001428336 · Accession: 0000000000-22-011045
AI Filing Summary & Sentiment
File numbers found in text: 001-36568
Letter
United States securities and exchange commission logo October 6, 2022 Tyson Murdock Executive Vice President and Chief Financial Officer HealthEquity, Inc 15 West Scenic Pointe Drive Suite 100 Draper, Utah 84020 Re:HealthEquity, Inc Form 10-K for the Fiscal Year Ended January 31, 2022 Filed March 31, 2022 Form 10-Q for the Interim Period Ending April 30, 2022 Filed June 8, 2022 File No. 001-36568 Dear Tyson Murdock: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Trade & Services
Show Raw Text
United States securities and exchange commission logo
October 6, 2022
Tyson Murdock
Executive Vice President and Chief Financial Officer
HealthEquity, Inc
15 West Scenic Pointe Drive Suite 100
Draper, Utah 84020
Re:HealthEquity, Inc
Form 10-K for the Fiscal Year Ended January 31, 2022
Filed March 31, 2022
Form 10-Q for the Interim Period Ending April 30, 2022
Filed June 8, 2022
File No. 001-36568
Dear Tyson Murdock:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Trade & Services